确定脊柱肌肉缩的生物标志物,以进一步发展
Jacqueline Glascock1, Basil T Darras2, Thomas O Crawford3
1Cure SMA, Elk Grove Village, IL, USA.
Journal of neuromuscular diseases
|July 17, 2023
概括
神经纤维 (NF) 是脊髓肌肉缩 (SMA) 的生物标志物,有助于诊断和治疗反应. 需要进一步的研究来验证NF.
科学领域:
- 神经学 神经学
- 遗传学 是一个遗传学.
- 生物标志物发现发现
背景情况:
- 脊椎肌肉缩 (SMA) 是由SMN1基因突变引起的,导致运动神经元退化和肌肉衰弱.
- 在SMA中,疾病的严重程度和治疗反应是高度可变的,并未完全理解.
- 验证的生物标志物对于SMA诊断,预后和治疗优化至关重要.
研究的目的:
- 为了确定SMA最有前途的生物标志物候选者.
- 确定生物标志物验证中的知识差距.
- 建议SMA生物标志物开发的下一步步骤.
主要方法:
- 一个经过修改的Delphi过程,涉及11名多学科专家.
- 六轮代调查以达成关于SMA生物标志物的共识.
主要成果:
- 神经纤维 (NF) 被确定为SMA的主要候选生物标志物.
- 确定了关于NF作为SMA生物标志物的关键知识差距.
- 概述了解决发现的知识差距的建议策略.
结论:
- 神经纤维 (NF) 显示出作为SMA的预后,预测和药理动力学生物标志物的潜力.
- 确定了验证NF作为SMA生物标志物的必要信息.
- 建议继续努力验证NF在SMA的临床使用.
相关概念视频
01:21Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
01:15Myasthenia Gravis: Diagnostic Tests
1.0K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.0K